BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33420762)

  • 1. The timing of venous thromboembolism in ovarian cancer patients: A nationwide Danish cohort study.
    Strøm Kahr H; Christiansen OB; Juul Riddersholm S; Gade IL; Torp-Pedersen C; Knudsen A; Thorlacius-Ussing O
    J Thromb Haemost; 2021 Apr; 19(4):992-1000. PubMed ID: 33420762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and potential predictors of thromboembolic events in epithelial ovarian carcinoma patients during perioperative period.
    Zhou Q; Zhu C; Shen Z; Zhang T; Li M; Zhu J; Qin J; Xie Y; Zhang W; Chen R; Wang G; Qian L; Wu D; Nashan B; Zhou Y
    Eur J Surg Oncol; 2020 May; 46(5):855-861. PubMed ID: 32001042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea.
    Shin W; Lee S; Lim MC; Jung J; Kim HJ; Cho H
    Cancer Med; 2021 Mar; 10(6):2045-2053. PubMed ID: 33638309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in epithelial ovarian cancer. A prospective cohort study.
    Kahr HS; Christiansen OB; Grove A; Iyer V; Torp-Pedersen C; Knudsen A; Thorlacius-Ussing O
    Thromb Res; 2019 Sep; 181():112-119. PubMed ID: 31400621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of venous thromboembolism after debulking surgery for epithelial ovarian cancer.
    Mokri B; Mariani A; Heit JA; Weaver AL; McGree ME; Martin JR; Lemens MA; Cliby WA; Bakkum-Gamez JN
    Int J Gynecol Cancer; 2013 Nov; 23(9):1684-91. PubMed ID: 24172104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
    Shafa A; Watkins AB; McGree ME; Weroha SJ; Wahner Hendrickson AE; Block MS; Langstraat CL; McBane RD; Bakkum-Gamez JN; Kumar A
    Gynecol Oncol; 2023 Sep; 176():36-42. PubMed ID: 37442024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study.
    Gade IL; Riddersholm SJ; Christiansen I; Rewes A; Frederiksen M; Enggaard L; Poulsen CB; Bergmann OJ; Gillström DB; Pedersen RS; Nielsen L; Eriksen HH; Torp-Pedersen C; Kristensen SR; Severinsen MT
    Blood Adv; 2018 Nov; 2(21):3025-3034. PubMed ID: 30425066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic Venous Thromboembolism After Achilles Tendon Rupture: A Nationwide Danish Cohort Study of 28,546 Patients With Achilles Tendon Rupture.
    Pedersen MH; Wahlsten LR; Grønborg H; Gislason GH; Petersen MM; Bonde AN
    Am J Sports Med; 2019 Nov; 47(13):3229-3237. PubMed ID: 31574237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
    Xu Y; Jia Y; Zhang Q; Du Y; He Y; Zheng A
    Gynecol Oncol; 2021 Feb; 160(2):610-618. PubMed ID: 33221022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis.
    Wiegers HMG; Schaafsma M; Guman NAM; Zelisse HS; Mulder FI; Middeldorp S; van Es N; Mom CH
    J Thromb Haemost; 2023 Feb; 21(2):294-302. PubMed ID: 36700503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial cancer does not increase the 30-day risk of venous thromboembolism following hysterectomy compared to benign disease. A Danish National Cohort Study.
    Kahr HS; Christiansen OB; Høgdall C; Grove A; Mortensen RN; Torp-Pedersen C; Knudsen A; Thorlacius-Ussing O
    Gynecol Oncol; 2019 Oct; 155(1):112-118. PubMed ID: 31378374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer.
    Chokshi SK; Gaughan JP; Krill L
    J Thromb Thrombolysis; 2022 Jan; 53(1):202-207. PubMed ID: 34185227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs.
    Chong W; Bui AH; Menhaji K
    Am J Obstet Gynecol; 2020 Aug; 223(2):268.e1-268.e26. PubMed ID: 32413430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Clinical Characteristic of Venous Thromboembolism in Gynecologic Oncology Patients attending King Chulalongkorn Memorial Hospital over a 10 Year Period.
    Oranratanaphan S; Termrungruanglert W; Khemapech N
    Asian Pac J Cancer Prev; 2015; 16(15):6705-9. PubMed ID: 26434898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins, aspirin and risk of thromboembolic events in ovarian cancer patients.
    Shai A; Rennert HS; Rennert G; Sagi S; Leviov M; Lavie O
    Gynecol Oncol; 2014 May; 133(2):304-8. PubMed ID: 24631448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study.
    Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Yoon SH; Kim YB
    PLoS One; 2021; 16(4):e0250723. PubMed ID: 33909674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
    Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
    Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
    Salinaro JR; McQuillen K; Stemple M; Boccaccio R; Ehrisman J; Lorenzo AM; Havrilesky L; Secord AA; Galvan Turner V; Moore KN; Davidson B
    Int J Gynecol Cancer; 2020 Apr; 30(4):491-497. PubMed ID: 32054646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk and timing of venous thromboembolism in patients with gastrointestinal cancer: a nationwide Danish cohort study.
    Tønnesen J; Pallisgaard J; Rasmussen PV; Ruwald MH; Lamberts M; Nouhravesh N; Strange J; Gislason GH; Hansen ML
    BMJ Open; 2023 Jan; 13(1):e062768. PubMed ID: 36657765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The survival detriment of venous thromboembolism with epithelial ovarian cancer.
    Gunderson CC; Thomas ED; Slaughter KN; Farrell R; Ding K; Farris RE; Lauer JK; Perry LJ; McMeekin DS; Moore KN
    Gynecol Oncol; 2014 Jul; 134(1):73-7. PubMed ID: 24793732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.